Overview

Eniluracil Hand Foot Syndrome

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
A pilot study of eniluracil containing ointment for prevention of hand foot syndrome (HRS) following capecitabine (Xeloda).
Phase:
Phase 1
Details
Lead Sponsor:
West Virginia University
Collaborator:
Investigator initiated study
Treatments:
Capecitabine
Eniluracil